Literature DB >> 24389086

Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors.

Kui Luo1, Bin He1, Yao Wu1, Youqing Shen2, Zhongwei Gu3.   

Abstract

Gene therapy has provided great potential to revolutionize the treatment of many diseases. This therapy is strongly relied on whether a delivery vector efficiently and safely directs the therapeutic genes into the target tissue/cells. Nonviral gene delivery vectors have been emerging as a realistic alternative to the use of viral analogs with the potential of a clinically relevant output. Dendritic polymers were employed as nonviral vectors due to their branched and layered architectures, globular shape and multivalent groups on their surface, showing promise in gene delivery. In the present review, we try to bring out the recent trend of studies on functional and biodegradable dendritic polymers as nontoxic and efficient gene delivery vectors. By regulating dendritic polymer design and preparation, together with recent progress in the design of biodegradable polymers, it is possible to precisely manipulate their architectures, molecular weight and chemical composition, resulting in predictable tuning of their biocompatibility as well as gene transfection activities. The multifunctional and biodegradable dendritic polymers possessing the desirable characteristics are expected to overcome extra- and intracellular obstacles, and as efficient and nontoxic gene delivery vectors to move into the clinical arena.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Biodegradable; Dendrimer; Dendritic polymers; Functionalization; Gene therapy; Gene transfection; Gene vectors

Mesh:

Substances:

Year:  2014        PMID: 24389086     DOI: 10.1016/j.biotechadv.2013.12.008

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  6 in total

1.  Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart.

Authors:  Chenglu Xiao; Fang Wang; Junjie Hou; Xiaojun Zhu; Ying Luo; Jing-Wei Xiong
Journal:  J Vis Exp       Date:  2018-07-29       Impact factor: 1.355

2.  Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo.

Authors:  Saghir Akhtar; Bashayer Al-Zaid; Ahmed Z El-Hashim; Bindu Chandrasekhar; Sreeja Attur; Mariam H M Yousif; Ibrahim F Benter
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 3.  Evolution from Covalent to Self-Assembled PAMAM-Based Dendrimers as Nanovectors for siRNA Delivery in Cancer by Coupled In Silico-Experimental Studies. Part I: Covalent siRNA Nanocarriers.

Authors:  Domenico Marson; Erik Laurini; Suzana Aulic; Maurizio Fermeglia; Sabrina Pricl
Journal:  Pharmaceutics       Date:  2019-07-18       Impact factor: 6.321

4.  Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury.

Authors:  Fawzi Babiker; Ibrahim F Benter; Saghir Akhtar
Journal:  Int J Nanomedicine       Date:  2020-06-19

5.  Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.

Authors:  Anthony S Fargnoli; Anbin Mu; Michael G Katz; Richard D Williams; Kenneth B Margulies; David B Weiner; Shu Yang; Charles R Bridges
Journal:  J Transl Med       Date:  2014-06-16       Impact factor: 5.531

Review 6.  Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.

Authors:  Piotr Tarach; Anna Janaszewska
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.